Annual EBITDA
$10.89B$119.00M+1.10%
Summary
- Current Value
- As of today, TMO annual EBITDA is $10.89B, up +1.10% on
- Historical Performance
- TMO annual EBITDA is down -8.54% over the past 3 years, up +6.53% over the past 5 years
- All-Time High Comparison
- TMO annual EBITDA is currently -15.65% below its historical high of $12.91B set on
- 3-Year Low Comparison
- TMO annual EBITDA is +1.10% above its 3-year low of $10.77B reached on
- Sector Comparison
- TMO annual EBITDA is higher than 98.54% of companies in Healthcare sector
EBITDA Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $10.89B | +1.1% | -8.5% | +6.5% | +443.3% | |
| Quarterly EBITDA | $2.71B | +6.4% | +5.6% | -26.8% | +413.6% | |
| TTM EBITDA | $11.34B | +5.5% | +5.3% | -8.7% | +433.4% | |
| Price | $451.79 | +13.4% | -14.3% | -2.3% | +593.1% | |
| PE Ratio | 24.84 | +6.3% | -27.8% | +6.8% | -0.1% | |
| Annual Revenue | $44.56B | +3.9% | -0.8% | +38.3% | +328.7% | |
| Annual EPS | $17.74 | +7.2% | +0.5% | +11.0% | +603.0% | |
| Annual EBIT | $8.11B | +5.8% | -4.9% | +2.7% | +541.3% | |
| Annual Net Income | $6.72B | +6.0% | -3.5% | +5.4% | +581.6% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $11.91B | N/A | -8.5% |
| 5Y | $12.91B | -15.7% | |
| All | $12.91B | -15.7% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $10.77B | +1.1% | |
| 5Y | $10.22B | N/A | +6.5% |
| All | $7.15M | >+9999.0% |
EBITDA History
FAQ
What is the current annual EBITDA of TMO?
As of today, TMO annual EBITDA is $10.89B
What is 1-year change in TMO annual EBITDA?
TMO annual EBITDA is up +1.10% year-over-year
What is 3-year change in TMO annual EBITDA?
TMO annual EBITDA is down -8.54% over the past 3 years
How far is TMO annual EBITDA from its all-time high?
TMO annual EBITDA is currently -15.65% below its historical high of $12.91B set on December 31, 2021
How does TMO annual EBITDA rank versus sector peers?
TMO annual EBITDA is higher than 98.54% of companies in Healthcare sector
When is TMO next annual earnings release?
As of today, the next annual earnings release for TMO has not been scheduled
Quarterly EBITDA
$2.71B$474.00M-14.90%
Summary
- Current Value
- As of today, TMO quarterly EBITDA is $2.71B, down -14.90% on
- Historical Performance
- TMO quarterly EBITDA is up +6.37% year-over-year, up +5.62% over the past 3 years
- All-Time High Comparison
- TMO quarterly EBITDA is currently -27.58% below its historical high of $3.74B set on
- 3-Year Low Comparison
- TMO quarterly EBITDA is +6.37% above its 3-year low of $2.55B reached on
- Sector Comparison
- TMO quarterly EBITDA is higher than 98.52% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $2.71B | -14.9% | +6.4% | +5.6% | -26.8% | |
| Annual EBITDA | $10.89B | – | +1.1% | -8.5% | +6.5% | |
| TTM EBITDA | $11.34B | +1.4% | +5.5% | +5.3% | -8.7% | |
| Price | $451.79 | -11.6% | +13.4% | -14.3% | -2.3% | |
| PE Ratio | 24.84 | -13.8% | +6.3% | -27.8% | +6.8% | |
| Quarterly Revenue | $11.01B | -9.9% | +6.2% | +2.8% | +11.1% | |
| Quarterly EPS | $4.43 | -15.0% | +11.3% | +33.2% | -24.8% | |
| Quarterly EBIT | $1.91B | -22.1% | +3.9% | +12.2% | -37.8% | |
| Quarterly Net Income | $1.66B | -15.9% | +9.6% | +28.2% | -29.1% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $3.18B | -14.9% | |
| 3Y | $3.18B | -14.9% | |
| 5Y | $3.70B | -26.9% | |
| All | $3.74B | -27.6% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $2.55B | N/A | +6.4% |
| 3Y | $2.55B | +6.4% | |
| 5Y | $2.55B | +6.4% | |
| All | -$331.10M | +917.6% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of TMO?
As of today, TMO quarterly EBITDA is $2.71B
What is TMO quarterly EBITDA most recent change?
TMO quarterly EBITDA was down -14.90% on March 28, 2026
What is 1-year change in TMO quarterly EBITDA?
TMO quarterly EBITDA is up +6.37% year-over-year
How far is TMO quarterly EBITDA from its all-time high?
TMO quarterly EBITDA is currently -27.58% below its historical high of $3.74B set on December 31, 2020
How does TMO quarterly EBITDA rank versus sector peers?
TMO quarterly EBITDA is higher than 98.52% of companies in Healthcare sector
When is TMO next earnings release?
The next earnings release for TMO is on
TTM EBITDA
$11.34B$162.00M+1.45%
Summary
- Current Value
- As of today, TMO TTM EBITDA is $11.34B, up +1.45% on
- Historical Performance
- TMO TTM EBITDA is up +5.48% year-over-year, up +5.27% over the past 3 years
- All-Time High Comparison
- TMO TTM EBITDA is currently -14.90% below its historical high of $13.32B set on
- 3-Year Low Comparison
- TMO TTM EBITDA is +7.15% above its 3-year low of $10.58B reached on
- Sector Comparison
- TMO TTM EBITDA is higher than 98.61% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $11.34B | +1.4% | +5.5% | +5.3% | -8.7% | |
| Annual EBITDA | $10.89B | – | +1.1% | -8.5% | +6.5% | |
| Quarterly EBITDA | $2.71B | -14.9% | +6.4% | +5.6% | -26.8% | |
| Price | $451.79 | -11.6% | +13.4% | -14.3% | -2.3% | |
| PE Ratio | 24.84 | -13.8% | +6.3% | -27.8% | +6.8% | |
| TTM Revenue | $45.20B | +1.4% | +5.4% | +3.2% | +25.9% | |
| TTM EPS | $18.19 | +2.5% | +6.7% | +18.6% | -8.5% | |
| TTM EBIT | $8.47B | +0.9% | +9.0% | +14.6% | -15.7% | |
| TTM Net Income | $6.87B | +2.2% | +5.3% | +13.8% | -13.4% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $11.34B | at high | |
| 3Y | $11.34B | at high | |
| 5Y | $13.32B | -14.9% | |
| All | $13.32B | -14.9% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $10.75B | N/A | +5.5% |
| 3Y | $10.58B | +7.2% | |
| 5Y | $10.58B | +7.2% | |
| All | -$36.90M | >+9999.0% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of TMO?
As of today, TMO TTM EBITDA is $11.34B
What is TMO TTM EBITDA most recent change?
TMO TTM EBITDA was up +1.45% on March 28, 2026
What is 1-year change in TMO TTM EBITDA?
TMO TTM EBITDA is up +5.48% year-over-year
How far is TMO TTM EBITDA from its all-time high?
TMO TTM EBITDA is currently -14.90% below its historical high of $13.32B set on September 1, 2021
How does TMO TTM EBITDA rank versus sector peers?
TMO TTM EBITDA is higher than 98.61% of companies in Healthcare sector
When is TMO next earnings release?
The next earnings release for TMO is on
EBITDA Formula
Data Sources & References
- TMO Official Website www.thermofisher.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/97745/000009774526000012/0000097745-26-000012-index.htm
- TMO Profile on Yahoo Finance finance.yahoo.com/quote/TMO
- TMO Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/tmo